DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 2.67% to $721.05 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.46% to 7,365.12 and the Dow Jones Industrial Average rising 1.24% to 49,910.59.
Regeneron Pharmaceuticals Inc. closed 12.19% below its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 0.46% to $331.11, Moderna Inc. (MRNA) rose 4.45% to $48.79, and Gilead Sciences Inc. (GILD) rose 2.11% to $136.30.
Trading volume (738,420) eclipsed its 50-day average volume of 672,890.
Data source: Dow Jones Market Data, FactSet. Data compiled May 6, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 06, 2026 16:44 ET (20:44 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments